Skip to main content
SpringerLink
Log in

Reaktivierung des Varizella-Zoster-Virus

Diagnostik, Therapie und Prophylaxe des Herpes zoster

  • Fortbildung
  • Diagnostik, Therapie und Prophylaxe des Herpes zoster
  • Published:
hautnah dermatologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

© Clinical Photography / Science Photo Library

Literatur

  1. Civen R et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementationof varicella vaccination. Pediatr Infect Dis J. 2009; 28: 954-9

  2. Moodley A et al. Severe herpes zoster following varicella vaccination in immunocompetent young children. J Child Neurol. 2019; 34: 184-8

  3. Anonymous. Ständige Impfkommission (STIKO): Wissenschaftliche Begründung für die Entscheidung, die Herpes zoster Lebendimpfung nicht als Standardimpfung zu empfehlen. Epidemiol Bull. 2017; 36: 391-411

  4. Gross GE et al. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e. V.(AWMF)-S2k- Leitlinie "Diagnostik und Therapie des Zoster und der Postzosterneuralgie". 2019

  5. Meister W et al. Demography, symptomatology, and course of disease in ambulatory zoster patients. A physician-based survey in Germany. Intervirology. 1998; 41: 272-7

  6. Kilgore PE et al. Varicella in Americans from NHANES III: implications for control through routine immunization. J Med Virol. 2003; 70: 111-8

  7. Brisson M et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect. 2001; 127: 305-14

  8. Hillebrand K et al. Incidence of herpes zoster and its complications in Germany, 2005-2009. J Infect. 2015; 70: 178-86

  9. Ultsch B et al. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis. 201; 11: 173

  10. Yawn BP et al. Herpes zoster recurrences more frequent than previously reported. Mayo ClinProc. 2011; 86: 88-93

  11. Civen R et al. Update on incidence of herpes zoster among children and adolescents after implementation of varicella vaccination, Antelope Valley, CA, 2000 to 2010. Pediatr Infect Dis J. 2016; 35: 1132-6

  12. Zoch-Lesniak B et al. Trends in herpes zoster epidemiology in Germany based on primary care sentinel surveillance data, 2005-2016. Hum Vaccin Immunother. 2018; 14: 1807-14

  13. Forbes HJ et al. Quantification of risk factors for herpes zoster: population based case-control study. BMJ. 2014; 348: g2911

  14. Chen HH et al. Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort. Clinics (SaoPaulo). 2011; 66: 1177-82

  15. Ferreira JC et al. Herpes zoster infection in childhood-onset systemic lupus erythematosus patients: a large multicenter study. Lupus. 2016; 25: 754-759

  16. Strangfeld A et al. OP0238: risk of herpes zoster in patients with rheumatoid arthritis under biological, targeted synthetic and conventional syntetic DMARD treatment. Ann Rheum Dis. 2020; 79: 150

  17. Meister W et al. A prognostic score for postherpetic neuralgia in ambulatory patients. Infection. 1998; 26: 359-63

  18. Oxman MN et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005; 352: 2271-84

  19. Rieck T et al. Assessing varicella vaccine effectiveness and its influencing factors using health insurance claimsdata, Germany, 2006 to 2015. Euro Surveill. 2017; 22: 30521

  20. Anonymous. Ständige Impfkommission (STIKO): Wissenschaftliche Begründung zur Empfehlung einer Impfung mit dem Herpes-zoster-Subunit- Totimpfstoff. Epidemiol Bull. 2018; 50: 541-67

  21. Cunningham AL et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med.2016; 375: 1019-32

  22. Lal H et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015; 372: 2087-96

  23. Hügler P et al. Prevention of postherpetic neuralgia with varicella- zoster hyperimmune globulin. Eur J Pain. 2002; 6: 435-45

  24. Wagner N et al. Impfen bei Immundefizienz. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019; 62: 494-515

  25. Bastidas A et al. Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial. JAMA. 2019; 322: 123-33

  26. Berkowitz EM et al. Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1/2a randomized, placebo- controlled study. J Infect Dis. 2015; 211: 1279-87

  27. Dagnew AF et al. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis. Lancet Infect Dis. 2019; 19: 988-1000

  28. Vink P et al. Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: a phase 3, randomized clinical trial. Clin Infect Dis. 2020; 70: 181-90

  29. Stevens E et al. Safety of the zoster vaccine recombinant adjuvanted in rheumatoid arthritis and other systemic rheumatic disease patients: a single center's experience with 400 patients. ACR Open Rheumatol. 2020; 2: 357-61

Download references

Author information

Authors and Affiliations

  1. Bad Abbach, Germany

    Boris Ehrenstein

Authors
  1. Boris Ehrenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Boris Ehrenstein.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ehrenstein, B. Diagnostik, Therapie und Prophylaxe des Herpes zoster. hautnah dermatologie 37, 32–41 (2021). https://doi.org/10.1007/s15012-021-6618-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15012-021-6618-8

Search

Navigation